
October 25, 2023
TCT DurAVR® THV EFS Data Presentation
At TCT 2023, Dr Azeem Latib presented the preliminary results from the DurAVR® THV US Early Feasibility Study. View the slides from the presentation to learn about the design of the biomimetic THV and see the paradigm-shifting hemodynamic results at discharge for all 15 enrolled patients.